Fig. 1 · Structure
Documents & Downloads
TG6-129
EP2 Receptor Antagonist
TG6-129 is a selective antagonist of the EP2 receptor, primarily involved in modulating inflammatory responses. This compound has been shown to reduce the expression of inflammatory factors induced by butaprost in P388D1 macrophages. TG6-129 is valuable for researchers studying inflammation and related signaling pathways.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 1164464-14-5 |
| Applications | EP2 Receptor Antagonist |
| Formula | C20H18FN5O3S3 |
| Molecular Weight | 491.58 |
| SMILES | O=C(NC(NC1=CC=C(S(=O)(NC2=NN=C(CC)S2)=O)C=C1)=S)/C=C/C3=CC=C(F)C=C3 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.